More articles about: Metabolism, Endocrinology & Diabetes

A pre-clinical study explores the role of hormones in the COVID-19 vascular damage that’s generally worse in men than in women.

Research finds COVID-19 associated with mental health problems after discharge, with majority not recognizing significant symptoms as a concern.

Endocrinologist Amy Rothberg, M.D. joins us to talk about weight loss and the most commonly searched questions about weight management.

In collaboration with the CDC, Michigan Medicine has piloted a clinical pharmacist program that is proving to be highly effective in helping patients manage hypertension.

Diabetes care should include medication to reduce blood sugar, cholesterol and blood pressure, and counseling on diet, weight and exercise. But few people in developing nations receive all of this.

A team explores the possible association between human genetic variants and liver attenuation that may also indicate a new pathway for lowering triglycerides and cholesterol.

Preclinical study identifies possible therapeutic target for cardiovascular risk factors that avoid the common problem of an increased risk of fatty liver disease.

New findings give reason to pay attention to metabolic dysfunction well before middle age.

The institute will pursue diabetes research and life-changing therapies

While insulin comprises a big part of diabetes expenses for children and adults, diabetes-related supplies can cost even more.

The most read stories of 2019 on the Michigan Health Lab blog.

An innovative team at Michigan Medicine’s Arvan Lab reveals how proinsulin misfolding is a hallmark of prediabetes that can worsen the condition.

A new discovery points towards a possible treatment for non-healing, diabetic wound care

New federal health insurance rule could save on out-of-pocket costs for patients managing chronic conditions.

In a U-M study, researchers observed a reversal of chronic nerve damage in prediabetic mice that were fed unsaturated dietary fats.